0001567619-21-005639.txt : 20210304 0001567619-21-005639.hdr.sgml : 20210304 20210304155611 ACCESSION NUMBER: 0001567619-21-005639 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210304 DATE AS OF CHANGE: 20210304 EFFECTIVENESS DATE: 20210304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HDL THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001569047 IRS NUMBER: 273015978 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391267 FILM NUMBER: 21714042 BUSINESS ADDRESS: STREET 1: 601 21ST STREET STREET 2: SUITE 300 CITY: VERO BEACH STATE: FL ZIP: 32960 BUSINESS PHONE: 772-453-2770 MAIL ADDRESS: STREET 1: 601 21ST STREET STREET 2: SUITE 300 CITY: VERO BEACH STATE: FL ZIP: 32960 D 1 primary_doc.xml X0708 D LIVE 0001569047 HDL THERAPEUTICS, INC. 601 21ST STREET SUITE 300 VERO BEACH FL FLORIDA 32960 772-453-2770 DELAWARE None None Corporation true Michael Matin c/o HDL Therapeutics, Inc. 601 21st Street, Suite 300 Vero Beach FL FLORIDA 32960 Executive Officer Director Mr. Matin is the Chief Executive Officer and Secretary of the Issuer. Bryan Brewer c/o HDL Therapeutics, Inc. 601 21st Street, Suite 300 Vero Beach FL FLORIDA 32960 Executive Officer Director Dr. Brewer is the Chief Scientific Officer of the Issuer. Dane Andreeff c/o HDL Therapeutics, Inc. 601 21st Street, Suite 300 Vero Beach FL FLORIDA 32960 Director Biotechnology Decline to Disclose 06b false 2021-02-19 false true true Series E Preferred Stock false 0 None None Frontier Solutions, LLC 136102 3307 Church Road, Suite 220 Richmond VA VIRGINIA 23233 AL ALABAMA AR ARKANSAS AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA DE DELAWARE FL FLORIDA GA GEORGIA IA IOWA ID IDAHO IL ILLINOIS IN INDIANA KS KANSAS KY KENTUCKY LA LOUISIANA MA MASSACHUSETTS MD MARYLAND MI MICHIGAN MN MINNESOTA MO MISSOURI MS MISSISSIPPI NC NORTH CAROLINA NE NEBRASKA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NV NEVADA NY NEW YORK OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA VT VERMONT WA WASHINGTON WI WISCONSIN WV WEST VIRGINIA WY WYOMING false 50000000 3355237 46644763 false 31 0 0 The Issuer has entered into a placement agent agreement with the persons named in Item 12 under which terms such persons will receive sales commissions and other fees based on the amount of approved sales. Such amounts are unknown at this time. 0 false HDL THERAPEUTICS, INC. /s/ Michael Matin Michael Matin Chief Executive Officer of the Issuer 2021-03-04